Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Novo A/s
Relationship:   10% Owner
City:   Bagsvaerd
State:   G7
   
Insider Summary:
  
   
Companies Owned :   43    
Direct Shares   93,548,310    

Indirect Shares

   0      
Direct Value   $749,128,598    

Indirect Value

   $0      
Total Shares   93,548,310      
Total Value   $749,128,598      


Inogen Inc $17,965,325 Flexion Therapeutics Inc $19,454,155 Akebia Therapeutics, Inc. $1,668,026 Alder Biopharmaceuticals Inc $60,438,335 Zs Pharma, Inc. $0 Otonomy, Inc. $0 Nevro Corp $21,531,390 Tobira Therapeutics Inc $0 Colucid Pharmaceuticals, Inc. $0 Corvus Pharmaceuticals, Inc. $2,973,526 Reata Pharmaceuticals Inc $102,173,974 Irhythm Technologies, Inc. $192,453,744 Ra Pharmaceuticals, Inc. $95,402,152 Apollo Endosurgery, Inc $13,018,420 Anaptysbio Inc $48,492,564 Entasis Therapeutics Holdings Inc. $4,778,236 Milestone Pharmaceuticals Inc. $0 Morphic Holding, Inc. $77,405,750 Mirum Pharmaceuticals, Inc. $0 Galera Therapeutics, Inc. $456,394 Nkarta, Inc. $0 Inozyme Pharma, Inc. $0 Checkmate Pharmaceuticals, Inc. $22,700,895 Harmony Biosciences Holdings, Inc. $0 Spruce Biosciences, Inc. $0 Praxis Precision Medicines, Inc. $0 Aligos Therapeutics, Inc. $0 Eargo, Inc. $0 Galecto Inc. $0 Bolt Biotherapeutics, Inc. $2,833,553 Edgewise Therapeutics, Inc. $0 Reneo Pharmaceuticals, Inc. $6,094,517 Cyteir Therapeutics, Inc. $10,636,851 Verve Therapeutics, Inc. $0 Minerva Surgical Inc $0 Io Biotech, Inc. $0 Arcellx, Inc. $0 Disc Medicine, Inc $36,180,907 Metagenomi, Inc. $12,469,885 Inogen Inc $17,965,325 Flexion Therapeutics Inc $19,454,155 Akebia Therapeutics, Inc. $1,668,026 Alder Biopharmaceuticals Inc $60,438,335 Zs Pharma, Inc. $0 Otonomy, Inc. $0 Nevro Corp $21,531,390 Tobira Therapeutics Inc $0 Colucid Pharmaceuticals, Inc. $0 Corvus Pharmaceuticals, Inc. $2,973,526 Reata Pharmaceuticals Inc $102,173,974 Irhythm Technologies, Inc. $192,453,744 Ra Pharmaceuticals, Inc. $95,402,152 Apollo Endosurgery, Inc $13,018,420 Anaptysbio Inc $48,492,564 Entasis Therapeutics Holdings Inc. $4,778,236 Milestone Pharmaceuticals Inc. $0 Morphic Holding, Inc. $77,405,750 Mirum Pharmaceuticals, Inc. $0 Galera Therapeutics, Inc. $456,394 Nkarta, Inc. $0 Inozyme Pharma, Inc. $0 Checkmate Pharmaceuticals, Inc. $22,700,895 Harmony Biosciences Holdings, Inc. $0 Spruce Biosciences, Inc. $0 Praxis Precision Medicines, Inc. $0 Aligos Therapeutics, Inc. $0 Eargo, Inc. $0 Galecto Inc. $0 Bolt Biotherapeutics, Inc. $2,833,553 Edgewise Therapeutics, Inc. $0 Reneo Pharmaceuticals, Inc. $6,094,517 Cyteir Therapeutics, Inc. $10,636,851 Verve Therapeutics, Inc. $0 Minerva Surgical Inc $0 Io Biotech, Inc. $0 Arcellx, Inc. $0 Disc Medicine, Inc $36,180,907 Metagenomi, Inc. $12,469,885
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    26    

     Stock price went up :
    0   
    14    
     Stock price went down :
    5   
    12    
   
     Gain/Loss Ratio :
   -5.0   
   1.2   
     Percentage Gain/Loss :
   -52.1%
 -223.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomimetic Therapeutics, Inc. BMTI 10% Owner 2013-03-01 0 2006-05-11 0    Premium*  
            Iveric Bio Inc ISEE 10% Owner 2016-12-15 0 2013-09-30 0    Premium*  
            Inogen Inc INGN 10% Owner 2021-06-02 2,079,320 0    Premium*  
            Flexion Therapeutics Inc FLXN 10% Owner 2015-06-22 2,133,131 2014-02-18 0    Premium*  
            Akebia Therapeutics, Inc. AKBA SEE REMARKS, 10% Owner 2014-03-25 1,516,387 2014-03-25 0    Premium*  
            Alder Biopharmaceuticals Inc ALDR SEE REMARKS, 10% Owner 2014-05-13 3,201,183 2014-05-13 0    Premium*  
            Zs Pharma, Inc. ZSPH See Remarks, 10% Owner 2014-06-23 781,730 2014-06-23 0    Premium*  
            Otonomy, Inc. OTIC SEE REMARKS, 10% Owner 2014-08-19 2,175,025 2014-08-18 0    Premium*  
            Nevro Corp NVRO SEE REMARKS, 10% Owner 2014-11-12 2,194,841 2014-11-12 0    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 2016-07-13 1,875,905 2015-05-04 0    Premium*  
            Htg Molecular Diagnostics, Inc HTGM 10% Owner 2017-08-25 0 2015-05-11 0    Premium*  
            Colucid Pharmaceuticals, Inc. CLCD 10% Owner 2016-09-09 3,156,563 2015-05-11 0    Premium*  
            Corvus Pharmaceuticals, Inc. CRVS 10% Owner 2020-07-08 1,389,498 2016-03-29 0    Premium*  
            Reata Pharmaceuticals Inc RETA 10% Owner 2017-06-14 592,794 2016-06-01 0    Premium*  
            Irhythm Technologies, Inc. IRTC 10% Owner 2016-10-25 2,124,448 0    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2016-10-31 2,031,562 2016-10-31 0    Premium*  
            Kalvista Pharmaceuticals Inc KALV 10% Owner 2017-10-12 0 0    Premium*  
            Apollo Endosurgery, Inc APEN 10% Owner 2017-07-26 1,301,842 0    Premium*  
            Anaptysbio Inc ANAB 10% Owner 2017-08-21 1,936,604 2017-01-31 0    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX 10% Owner 2018-09-28 2,181,843 2018-09-28 0    Premium*  
            Milestone Pharmaceuticals Inc. MIST 10% Owner 2019-05-13 2,674,470 2019-05-13 0    Premium*  
            Morphic Holding, Inc. MORF 10% Owner 2019-06-28 2,645,446 2019-06-28 0    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2019-07-22 2,445,147 2019-07-22 0    Premium*  
            Galera Therapeutics, Inc. GRTX 10% Owner 2021-02-18 2,459,021 2019-11-12 0    Premium*  
            Nkarta, Inc. NKTX 10% Owner 2020-07-14 2,793,865 2020-07-14 0    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2021-01-28 2,194,379 2020-07-28 0    Premium*  
            Checkmate Pharmaceuticals, Inc. CMPI 10% Owner 2022-02-25 2,161,990 2020-08-11 0    Premium*  
            Harmony Biosciences Holdings, Inc. HRMY 10% Owner 2020-08-21 3,754,973 2020-08-21 0    Premium*  
            Spruce Biosciences, Inc. SPRB 10% Owner 2024-03-21 2,550,000 2020-10-14 0    Premium*  
            Praxis Precision Medicines, Inc. PRAX 10% Owner 2020-10-20 2,442,080 2020-10-20 0    Premium*  
            Aligos Therapeutics, Inc. ALGS 10% Owner 2020-10-20 2,614,563 2020-10-20 0    Premium*  
            Eargo, Inc. EAR 10% Owner 2020-10-20 887,071 2020-10-20 0    Premium*  
            Galecto Inc. GLTO 10% Owner 2020-11-02 2,497,791 2020-11-02 0    Premium*  
            Bolt Biotherapeutics, Inc. BOLT 10% Owner 2022-07-13 3,703,991 0    Premium*  
            Edgewise Therapeutics, Inc. EWTX 10% Owner 2022-09-14 6,071,703 2021-03-30 0    Premium*  
            Reneo Pharmaceuticals, Inc. RPHM 10% Owner 2023-06-23 3,330,337 2021-04-13 0    Premium*  
            Cyteir Therapeutics, Inc. CYT 10% Owner 2023-07-20 3,522,136 2021-06-22 0    Premium*  
            Verve Therapeutics, Inc. VERV 10% Owner 2021-06-21 793,265 2021-06-21 0    Premium*  
            Minerva Surgical Inc UTRS 10% Owner 2021-10-26 2,057,132 2021-10-26 0    Premium*  
            Io Biotech, Inc. IOBT 2024-05-10 4,429,449 2021-11-09 0    Premium*  
            Arcellx, Inc. ACLX 10% Owner 2022-02-08 4,016,878 2022-02-08 0    Premium*  
            Disc Medicine, Inc IRON 10% Owner 2023-06-28 1,090,772 0    Premium*  
            Metagenomi, Inc. MGX 10% Owner 2024-02-13 1,739,175 2024-02-09 0    Premium*  
* Premium Members only  

Records found :    238         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 9 of 10
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CYT Cyteir Therapeutics, Inc. 10% Owner   –       –       •   2023-06-27 4 S $1.77 $56,687 D/D (31,978) 3,863,573 0 %
IRON Disc Medicine, Inc 10% Owner   –       –       •   2023-06-28 4 S $46.10 $57,625,000 D/D (1,250,000) 1,090,772 0 %
CYT Cyteir Therapeutics, Inc. 10% Owner   –       –       •   2023-06-30 4 S $2.63 $529,288 D/D (200,937) 3,662,636 0 %
CYT Cyteir Therapeutics, Inc. 10% Owner   –       –       •   2023-07-14 4 S $2.74 $30,102 D/D (11,000) 3,651,636 0 %
CYT Cyteir Therapeutics, Inc. 10% Owner   –       –       •   2023-07-17 4 S $2.75 $58,000 D/D (21,100) 3,630,536 0 %
CYT Cyteir Therapeutics, Inc. 10% Owner   –       –       •   2023-07-18 4 S $2.76 $17,923 D/D (6,500) 3,624,036 0 %
CYT Cyteir Therapeutics, Inc. 10% Owner   –       –       •   2023-07-19 4 S $2.76 $5,247 D/D (1,900) 3,622,136 0 %
CYT Cyteir Therapeutics, Inc. 10% Owner   –       –       •   2023-07-20 4 S $2.75 $275,140 D/D (100,000) 3,522,136 0 %
IOBT Io Biotech, Inc. 10% Owner   –       –       •   2023-08-09 4 B $2.03 $4,999,998 D/D 2,469,135 5,707,467 2.45 -
MGX Metagenomi, Inc. 10% Owner   –       –       •   2024-02-09 4 B $10.25 $1,025,000 D/D 100,000 100,000 2.45 -
IOBT Io Biotech, Inc. 10% Owner   –       –       •   2024-02-09 4 S $1.50 $988,411 D/D (658,809) 5,088,258 0 -
MGX Metagenomi, Inc. 10% Owner   –       –       •   2024-02-13 4 A $0.00 $0 D/D 839,175 939,175 0 -
MGX Metagenomi, Inc. 10% Owner   –       –       •   2024-02-13 4 B $15.00 $12,000,000 D/D 800,000 1,739,175 2.45 %
SPRB Spruce Biosciences, Inc. 10% Owner   –       –       •   2024-03-14 4 S $0.89 $1,698,902 D/D (1,912,316) 4,810,020 0 -
SPRB Spruce Biosciences, Inc. 10% Owner   –       –       •   2024-03-18 4 S $0.77 $647,008 D/D (842,020) 3,968,000 0 -
SPRB Spruce Biosciences, Inc. 10% Owner   –       –       •   2024-03-19 4 S $0.76 $447,715 D/D (593,000) 3,375,000 0 -
SPRB Spruce Biosciences, Inc. 10% Owner   –       –       •   2024-03-20 4 S $0.73 $264,081 D/D (359,979) 3,015,021 0 -
SPRB Spruce Biosciences, Inc. 10% Owner   –       –       •   2024-03-21 4 S $0.75 $350,951 D/D (465,021) 2,550,000 0 -
ISEE Iveric Bio Inc SEE REMARKS   –       –       •   2013-09-30 4 B $22.00 $10,010,000 D/D 455,000 6,896,819 2.45 -
ISEE Iveric Bio Inc SEE REMARKS   –       –       •   2013-09-30 4 A $0.00 $0 D/D 6,441,819 6,441,819 0 -
FLXN Flexion Therapeutics Inc SEE REMARKS   –       –       •   2014-02-18 4 B $13.00 $9,000,004 D/D 692,308 1,783,131 2.45 -
FLXN Flexion Therapeutics Inc SEE REMARKS   –       –       •   2014-02-18 4 A $0.00 $0 D/D 1,090,823 1,090,823 0 -
INGN Inogen Inc SEE REMARKS   –       –       •   2014-02-20 4 A $0.00 $0 D/D 5,948,056 6,036,449 0 -
INGN Inogen Inc SEE REMARKS   –       –       •   2014-02-20 4 S $14.88 $9,180,960 D/D (617,000) 5,419,449 0 -
AKBA Akebia Therapeutics, Inc. SEE REMARKS   –       –       •   2014-03-25 4 A $0.00 $0 D/D 1,333,797 1,333,797 0 -
  238  Records found
  1   2   3   4   5   6   7   8   9  10      
  Page 9 of 10  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us